Related Experiment Video
Updated: Jun 25, 2025

How to Use the H1 Deep Transcranial Magnetic Stimulation Coil for Conditions Other than Depression
Published on: January 23, 2017
Long-COVID symptoms improved after MDMA and psilocybin therapy: A case report
Harman Chopra1, Tim Furnish2, Monica Verduzco-Gutierrez3
1Johns Hopkins School of Medicine Baltimore Maryland USA.
Key Clinical Message:
Long-COVID syndrome lacks effective holistic treatment options. We present a case of a 41-year-old fully vaccinated female with Long-COVID syndrome who obtained significant symptomatic relief after self-medicating with psilocybin and MDMA.
Abstract:
Long-COVID, a syndrome persisting after the acute phase of coronavirus disease 2019 (COVID-19), lacks effective holistic treatment options. We present a case of a 41-year-old fully vaccinated female with Long-COVID syndrome who obtained significant symptomatic relief by self-prescribing psilocybin and MDMA. Future research is needed to assess safety and efficacy.
Related Concept Videos
CNS Stimulants: Psychedelic Agents
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Electroconvulsive Therapy

